Cytokinetics (CYTK) Tops Q3 EPS by 7c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ACCV
2. GMAB
3. IVBIY
4. IIB:IN
5. AZN
6. DRRD:IN
7. SMMT
8. RDY
9. CART
10. CLYM

Go back to Cytokinetics (CYTK) Tops Q3 EPS by 7c

Cytokinetics, Inc. Reports Third Quarter 2015 Financial Results

October 29, 2015 4:00 PM EDT

Recently Announced Positive Top-line Results From COSMIC-HF; Data Demonstrated Statistically Significant Improvements in Several Pre-Specified Measures of Cardiac Function

Company Lowers 2015 R&D Expense Guidance

SOUTH SAN FRANCISCO, Calif., Oct. 29, 2015 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq: CYTK) reported total research and development revenues for the third quarter of 2015 were $7.9 million, compared to $9.4 million during the same period in 2014.  The net loss for the third quarter was $8.8 million, or $0.23 per basic and diluted share. This is compared... More